Macquarie Adjusts MGM China’s Target Price to HKD21.6, Anticipates Hotel Room Enhancements to Increase Market Share
MGM CHINA's Financial Performance: MGM CHINA's 4Q25 results surpassed expectations, with net revenue rising 21% YoY to HKD9.62 billion, and GGR also increasing by 21% YoY to HKD10.5 billion.
Future Plans and Upgrades: The company plans to upgrade its hotel rooms this year, aiming to enhance its high-end appeal and increase market share.
Analyst Rating and Target Price: Macquarie has raised its target price for MGM CHINA by 1% to HKD21.6, maintaining an "Outperform" rating.
Short Selling Data: As of February 9, 2026, MGM CHINA has a short selling amount of $3.71 million, with a ratio of 5.019%.
Trade with 70% Backtested Accuracy
Analyst Views on 02282
About the author
<JPM Research> Highlights Top LNY Consumption Choices (Table)
Stock Performance: Several stocks, including Tencent, Laopu Gold, and MGM China, experienced declines in their prices, with short selling ratios indicating significant market activity.
Investment Ratings: Most of the stocks listed, such as Tencent and Laopu Gold, are rated as "Overweight," suggesting a positive outlook from analysts despite recent price drops.
Short Selling Data: The short selling data reveals varying levels of market skepticism, with Laopu Gold showing the highest short selling ratio at 22.243%.
Market Updates: BOCI has raised the target price for Luk Fook Holdings to HKD 35.9, highlighting it as an industry top pick amidst the current market conditions.
<Research>CLSA Anticipates Investor Attention on Potential Dividend Payout Ratio Increase by MGM CHINA (02282.HK)
Dividend Payout Focus: Investors are looking for indications that MGM CHINA will increase its annual dividend payout ratio from 50% to counterbalance rising license and branding fees, according to a CLSA report.
Stock Valuation and Rating: MGM CHINA's current valuation is at an EV/Ebitda multiple of 7.1x for 2026, with CLSA maintaining an Outperform rating and a target price of $20.9.
JPM Selects TENCENT, LAOPU GOLD, MGM CHINA, and TRIP.COM-S as Preferred Stocks; Maintains Optimism on Chinese Stock Market
JPMorgan's Trading Strategy: JPMorgan has recommended an upside options trading strategy focused on the Chinese consumer market ahead of the Chinese New Year, highlighting high-end baijiu, premium proteins, major condiments, gold, and tourism as key sectors.
Stock Market Outlook: The firm remains optimistic about the Chinese stock market but advises investors to be selective, naming TENCENT, LAOPU GOLD, MGM CHINA, TAL Education, TRIP.COM, HAITIAN FLAV, KWEICHOW MOUTAI, MENGNIU DAIRY, and WULIANGYE as top stock picks.
Macquarie Adjusts MGM China’s Target Price to HKD21.6, Anticipates Hotel Room Enhancements to Increase Market Share
MGM CHINA's Financial Performance: MGM CHINA's 4Q25 results surpassed expectations, with net revenue rising 21% YoY to HKD9.62 billion, and GGR also increasing by 21% YoY to HKD10.5 billion.
Future Plans and Upgrades: The company plans to upgrade its hotel rooms this year, aiming to enhance its high-end appeal and increase market share.
Analyst Rating and Target Price: Macquarie has raised its target price for MGM CHINA by 1% to HKD21.6, maintaining an "Outperform" rating.
Short Selling Data: As of February 9, 2026, MGM CHINA has a short selling amount of $3.71 million, with a ratio of 5.019%.
CICC Reports MGM CHINA (02282.HK) Exceeds 4Q25 Adjusted EBITDA Expectations, Maintains Outperform Rating
MGM China's Financial Performance: MGM China reported a net revenue of RMB9.617 billion in 4Q25, achieving 169% of the revenue from the same period in 2019, with adjusted EBITDA of RMB2.753 billion surpassing expectations.
High-End Business Growth: The strong performance was attributed to the high-end business segment, with MGM Cotai and MGM Macau's total GGR recovering to 214% and 104% of 2019 levels, respectively.
Broker Recommendations: CICC maintained its EBITDA forecasts for MGM China for 2026 and 2027, keeping an Outperform rating and a target price of HKD16.1.
Citi's Position: Citi reiterated a Buy rating on MGM China with a target price of HKD18.25, reflecting confidence in the company's ongoing recovery and performance.
UBS Assigns Buy Rating to MGM CHINA; Remains Positive on CNY Performance
Financial Performance: MGM CHINA's 4Q25 adjusted property EBITDA increased by 29% year-over-year to USD353 million, aligning with market expectations after adjustments for VIP room win rates.
Market Outlook: The company's management remains optimistic about the competitive environment and anticipates strong performance during the Chinese New Year holiday due to positive booking trends.
Stock Rating: UBS maintains a target price of HKD18.5 for MGM CHINA, with a "Buy" rating reflecting confidence in the company's future performance.
Short Selling Activity: The short selling for MGM CHINA is reported at $12.65 million, with a ratio of 10.407%, indicating a notable level of market speculation.
<JPM Research> Highlights Top LNY Consumption Choices (Table)
Stock Performance: Several stocks, including Tencent, Laopu Gold, and MGM China, experienced declines in their prices, with short selling ratios indicating significant market activity.
Investment Ratings: Most of the stocks listed, such as Tencent and Laopu Gold, are rated as "Overweight," suggesting a positive outlook from analysts despite recent price drops.
Short Selling Data: The short selling data reveals varying levels of market skepticism, with Laopu Gold showing the highest short selling ratio at 22.243%.
Market Updates: BOCI has raised the target price for Luk Fook Holdings to HKD 35.9, highlighting it as an industry top pick amidst the current market conditions.
<Research>CLSA Anticipates Investor Attention on Potential Dividend Payout Ratio Increase by MGM CHINA (02282.HK)
Dividend Payout Focus: Investors are looking for indications that MGM CHINA will increase its annual dividend payout ratio from 50% to counterbalance rising license and branding fees, according to a CLSA report.
Stock Valuation and Rating: MGM CHINA's current valuation is at an EV/Ebitda multiple of 7.1x for 2026, with CLSA maintaining an Outperform rating and a target price of $20.9.
JPM Selects TENCENT, LAOPU GOLD, MGM CHINA, and TRIP.COM-S as Preferred Stocks; Maintains Optimism on Chinese Stock Market
JPMorgan's Trading Strategy: JPMorgan has recommended an upside options trading strategy focused on the Chinese consumer market ahead of the Chinese New Year, highlighting high-end baijiu, premium proteins, major condiments, gold, and tourism as key sectors.
Stock Market Outlook: The firm remains optimistic about the Chinese stock market but advises investors to be selective, naming TENCENT, LAOPU GOLD, MGM CHINA, TAL Education, TRIP.COM, HAITIAN FLAV, KWEICHOW MOUTAI, MENGNIU DAIRY, and WULIANGYE as top stock picks.
Macquarie Adjusts MGM China’s Target Price to HKD21.6, Anticipates Hotel Room Enhancements to Increase Market Share
MGM CHINA's Financial Performance: MGM CHINA's 4Q25 results surpassed expectations, with net revenue rising 21% YoY to HKD9.62 billion, and GGR also increasing by 21% YoY to HKD10.5 billion.
Future Plans and Upgrades: The company plans to upgrade its hotel rooms this year, aiming to enhance its high-end appeal and increase market share.
Analyst Rating and Target Price: Macquarie has raised its target price for MGM CHINA by 1% to HKD21.6, maintaining an "Outperform" rating.
Short Selling Data: As of February 9, 2026, MGM CHINA has a short selling amount of $3.71 million, with a ratio of 5.019%.
CICC Reports MGM CHINA (02282.HK) Exceeds 4Q25 Adjusted EBITDA Expectations, Maintains Outperform Rating
MGM China's Financial Performance: MGM China reported a net revenue of RMB9.617 billion in 4Q25, achieving 169% of the revenue from the same period in 2019, with adjusted EBITDA of RMB2.753 billion surpassing expectations.
High-End Business Growth: The strong performance was attributed to the high-end business segment, with MGM Cotai and MGM Macau's total GGR recovering to 214% and 104% of 2019 levels, respectively.
Broker Recommendations: CICC maintained its EBITDA forecasts for MGM China for 2026 and 2027, keeping an Outperform rating and a target price of HKD16.1.
Citi's Position: Citi reiterated a Buy rating on MGM China with a target price of HKD18.25, reflecting confidence in the company's ongoing recovery and performance.
UBS Assigns Buy Rating to MGM CHINA; Remains Positive on CNY Performance
Financial Performance: MGM CHINA's 4Q25 adjusted property EBITDA increased by 29% year-over-year to USD353 million, aligning with market expectations after adjustments for VIP room win rates.
Market Outlook: The company's management remains optimistic about the competitive environment and anticipates strong performance during the Chinese New Year holiday due to positive booking trends.
Stock Rating: UBS maintains a target price of HKD18.5 for MGM CHINA, with a "Buy" rating reflecting confidence in the company's future performance.
Short Selling Activity: The short selling for MGM CHINA is reported at $12.65 million, with a ratio of 10.407%, indicating a notable level of market speculation.
